Pregled bibliografske jedinice broj: 229507
Alpha-fetoprotein and free beta chorionic gonadotropin as markers in biochemical screening for Down's syndrome and neural tube defects
Alpha-fetoprotein and free beta chorionic gonadotropin as markers in biochemical screening for Down's syndrome and neural tube defects // Clinical Chemistry and Laboratory Medicine / Gerard Siest, Marek H. Dominiczak (ur.).
Berlin: Walter de Gruyter, 1999. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 229507 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Alpha-fetoprotein and free beta chorionic gonadotropin as markers in biochemical screening for Down's syndrome and neural tube defects
Autori
Tišlarić, Dubravka ; Košec, Vesna ; Petek, Marijan ; Relja, Zoran ; Rušinović, Frane ; Ujević, Boris ; Miljan, Mladen
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Clinical Chemistry and Laboratory Medicine
/ Gerard Siest, Marek H. Dominiczak - Berlin : Walter de Gruyter, 1999
Skup
IFCC-WorldLab 17th International and 13th Europian Congress of Clinical Chemistry and Laboratory Medicine
Mjesto i datum
Firenca, Italija, 06.06.1999. - 11.06.1999
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
Down's syndrome; alpha-fetoprotein; free beta-hCG
Sažetak
OBJECTIVE: The evaluation of prenatal screening for Down's syndrome (DS) and neural tube defects (NTD), using alpha-fetoprotein (MS-AFP) and free beta chorionic gonadotropin (F-beta hCG) as biochemical markers. MATERIAL AND METHODS: The study was performed in 1185 women (13-21 gestational week). Serum markers were determined by immuno-radiometric assays (CIS, France). The calculation of individual risks was performed by the computer software ("Free-beta screen"). A patient was considered screen-positive for DS if the calculated risk was >/=1:250 ; MS-AFP >/= 2, 0 MoM was considered screen-positive for NTD. RESULTS: Out of 1185 women, 720 (60, 8%) were younger, and 465 (39, 2%) older than 35, respectively. A total of 130 (10, 9%) were DS screen-positive. The false-positive rate was 4% in younger and 20, 6% in older than 35, respectively. Five Down-syndrome fetuses were fund prenatally, three of them in women younger than 35. There were 20 (1, 7%) NTD screen-positive pregnancie, two babies have structural abnormalities confirmed by ultrasound. The perinatal oucome was ascertained in all tested pregnancies. CONCLUSION: Current results support the value of biochemical screening, particularly in younger population of pregnant women. Considering those older than 35, it could serve as a screening test according to the specific clinical circumstances and patient's individual choice or belief after being informed about the test.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Dubravka Tišlarić-Medenjak
(autor)
Mladen Miljan
(autor)
Frane Rušinović
(autor)
Marijan Petek
(autor)
Zoran Relja
(autor)